Investor insights
Sectors invested in
Biotechnology1
Health Care1
Therapeutics1
medical devices1
Hair Rejuvenation1
regenerative medicine1
cell therapy1
Tendinosis1
Skin Rejuvenation1
Tendon Repair1
tendinopathy1
biotechnology1
Androgenetic Alopecia1
Dermal Injector1
Funding rounds participated in
$2.1M sweet spot round size
Most of their 1 investments are in rounds between $2.1M and $2.1M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Pharmaceutical
Biopharma
Date founded
2017
Investments made
R
RepliCel Life Sciences Inc. raised $2.1M on January 25, 2021
Investors: MainPointe Pharmaceuticals